Taysha Gene Therapies (TSHA) Net Equity Issued and Repurchased (2020 - 2026)
Taysha Gene Therapies (TSHA) recorded Net Equity Issued and Repurchased of $516,000 in Q1 2026, up 588.0% from $75,000 a year earlier but down 49.6% from the prior quarter.
Powered by 
Analysis
Taysha Gene Therapies (TSHA) Net Equity Issued and Repurchased (2020 - 2026) Analysis & Trends
On a TTM basis, Taysha Gene Therapies' Net Equity Issued and Repurchased came in at $1.66 million as of Mar 31, 2026, up 912.8% year-over-year; for FY2025, it came in at $1.22 million.
- Annual Net Equity Issued and Repurchased has a five-year compound annual growth rate of -62.6% (FY2020 to FY2025).
- Across earlier years, Net Equity Issued and Repurchased came in at $89,000 in FY2024 (-82.2%), $500,000 in FY2023 (+97.6%) and $253,000 in FY2022.
- Quarterly Net Equity Issued and Repurchased has ranged from -$11.39 million in Q4 2022 to $1.02 million in Q4 2025 over the past five years.
- On a year-over-year basis, Net Equity Issued and Repurchased rose in three of the last four quarters, with growth averaging 196.0%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Taysha Gene Therapies | 1.58 Bn | 1.58 Bn | - | 441,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 441,000.00 |
| Mar 31, 2026 | 516,000.00 |
| Dec 31, 2025 | 1.02 Mn |
| Sep 30, 2025 | 122,000.00 |
| Mar 31, 2025 | 75,000.00 |
| Sep 30, 2024 | 63,000.00 |
| Mar 31, 2024 | 26,000.00 |
| Sep 30, 2023 | 450,000.00 |
| Mar 31, 2023 | 50,000.00 |
| Dec 31, 2022 | -11.39 Mn |
| Jun 30, 2022 | 11.36 Mn |
| Mar 31, 2022 | 277,000.00 |
| Dec 31, 2020 | -1.31 Mn |
| Sep 30, 2020 | 148.56 Mn |
| Jun 30, 2020 | 600,000.00 |
| Mar 31, 2020 | 18.00 Mn |
API Access
Taysha Gene Therapies Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=TSHA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "TSHA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=TSHA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();